ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,091Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 334

$1.45M Total Retail Price of All Prescriptions

Rank: 11 out of 334

267 Patients Receiving at Least One Drug in Part D
15%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 267 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 267 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

3% of this provider’s 451 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$204 was the average price of a prescription from this provider, compared to $130 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
TOPIRAMATE 513 0 1 28
LAMOTRIGINE 481 41 2 6
TRAZODONE HCL 418 28 3 1
ABILIFY 284 15 4 5
ZOLPIDEM TARTRATE 282 0 5 8
BENZTROPINE MESYLATE 235 14 R 6 9
CYMBALTA 219 0 7 3
LUNESTA 206 13 8 40
SAPHRIS 188 0 10 9 59
BUPROPION XL 137 20 10 16
VIIBRYD 135 0 11 51
CLONIDINE HCL 131 0 12 69
VENLAFAXINE HCL ER 125 27 13 12
QUETIAPINE FUMARATE 122 12 14 7
SUBOXONE 120 0 15 53
ZIPRASIDONE HCL 116 0 16 30
ROPINIROLE HCL 116 0 16 68
SEROQUEL XR 114 0 18 25
GABAPENTIN 108 0 19 29
AMPHETAMINE SALT COMBO 107 0 S2 20 37
NAMENDA 107 43 20 33
ESCITALOPRAM OXALATE 103 17 22 17
CARISOPRODOL 90 0 R 23 103
RISPERIDONE 87 13 24 2
NUEDEXTA 87 0 24 80
CITALOPRAM HBR 81 12 26 4
MIRTAZAPINE 81 18 26 13
DIVALPROEX SODIUM ER 79 13 28 14
ZALEPLON 76 0 29 111
INVEGA SUSTENNA 70 0 30 35
OLANZAPINE 69 20 31 15
OXCARBAZEPINE 67 0 32 32
EQUETRO 67 0 10 32 91
DOXEPIN HCL 65 0 34 44
NIZATIDINE 64 0 35 128
METFORMIN HCL 60 0 36 72
TRAMADOL HCL 60 0 36 94
SEROQUEL 60 0 36 27
INVEGA 59 0 39 34
DONEPEZIL HCL 56 20 40 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.